These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


136 related items for PubMed ID: 2315705

  • 1. Cartilage degradative enzymes in human osteoarthritis: effect of a nonsteroidal antiinflammatory drug administered orally.
    Vignon E, Mathieu P, Broquet P, Louisot P, Richard M.
    Semin Arthritis Rheum; 1990 Feb; 19(4 Suppl 1):26-9. PubMed ID: 2315705
    [Abstract] [Full Text] [Related]

  • 2. Phospholipase A2 activity in human osteoarthritic cartilage.
    Vignon E, Mathieu P, Louisot P, Vilamitjana J, Harmand MF, Richard M.
    J Rheumatol Suppl; 1989 Aug; 18():35-8. PubMed ID: 2553968
    [Abstract] [Full Text] [Related]

  • 3. The mechanism of action of nonsteroidal antiinflammatory drugs.
    Brandt KD.
    J Rheumatol Suppl; 1991 Feb; 27():120-1. PubMed ID: 2027109
    [Abstract] [Full Text] [Related]

  • 4. Effects of tenidap on the progression of osteoarthritic lesions in a canine experimental model. Suppression of metalloprotease and interleukin-1 activity.
    Fernandes JC, Caron JP, Martel-Pelletier J, Jovanovic D, Mineau F, Tardif G, Otterness IG, Pelletier JP.
    Arthritis Rheum; 1997 Feb; 40(2):284-94. PubMed ID: 9041940
    [Abstract] [Full Text] [Related]

  • 5. Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis.
    Martel-Pelletier J, McCollum R, Fujimoto N, Obata K, Cloutier JM, Pelletier JP.
    Lab Invest; 1994 Jun; 70(6):807-15. PubMed ID: 8015285
    [Abstract] [Full Text] [Related]

  • 6. In vitro effect of nonsteroidal antiinflammatory drugs on proteoglycanase and collagenase activity in human osteoarthritic cartilage.
    Vignon E, Mathieu P, Louisot P, Richard M.
    Arthritis Rheum; 1991 Oct; 34(10):1332-5. PubMed ID: 1657006
    [Abstract] [Full Text] [Related]

  • 7. Effects of tenidap on canine experimental osteoarthritis. I. Morphologic and metalloprotease analysis.
    Fernandes JC, Martel-Pelletier J, Otterness IG, Lopez-Anaya A, Mineau F, Tardif G, Pelletier JP.
    Arthritis Rheum; 1995 Sep; 38(9):1290-303. PubMed ID: 7575725
    [Abstract] [Full Text] [Related]

  • 8. Evidence for the involvement of interleukin 1 in human osteoarthritic cartilage degradation: protective effect of NSAID.
    Pelletier JP, Martel-Pelletier J.
    J Rheumatol Suppl; 1989 Aug; 18():19-27. PubMed ID: 2553967
    [Abstract] [Full Text] [Related]

  • 9. Study of the effect of a glycosaminoglycan-peptide complex on the degradative enzyme activities in human osteoarthritic cartilage.
    Vignon E, Martin A, Mathieu P, Conrozier T, Louisot P, Richard M.
    Clin Rheumatol; 1990 Sep; 9(3):383-8. PubMed ID: 2261738
    [Abstract] [Full Text] [Related]

  • 10. In vitro effects of tiaprofenic acid, sodium salicylate and hydrocortisone on the proteoglycan metabolism of human osteoarthritic cartilage.
    Pelletier JP, Cloutier JM, Martel-Pelletier J.
    J Rheumatol; 1989 May; 16(5):646-55. PubMed ID: 2754669
    [Abstract] [Full Text] [Related]

  • 11. Selective COX-2 inhibition is favorable to human early and late-stage osteoarthritic cartilage: a human in vitro study.
    Mastbergen SC, Bijlsma JW, Lafeber FP.
    Osteoarthritis Cartilage; 2005 Jun; 13(6):519-26. PubMed ID: 15922186
    [Abstract] [Full Text] [Related]

  • 12. Effects of SKI 306X, a new herbal agent, on proteoglycan degradation in cartilage explant culture and collagenase-induced rabbit osteoarthritis model.
    Choi JH, Choi JH, Kim DY, Yoon JH, Youn HY, Yi JB, Rhee HI, Ryu KH, Jung K, Han CK, Kwak WJ, Cho YB.
    Osteoarthritis Cartilage; 2002 Jun; 10(6):471-8. PubMed ID: 12056850
    [Abstract] [Full Text] [Related]

  • 13. [Cartilage changes in arthrosis--do non-steroidal antiphlogistics have positive or negative effects?].
    Ostensen M.
    Tidsskr Nor Laegeforen; 1991 Mar 10; 111(7):838-40. PubMed ID: 2020951
    [Abstract] [Full Text] [Related]

  • 14. Clinical aspects of chrondroprotection.
    Huskisson EC.
    Semin Arthritis Rheum; 1990 Feb 10; 19(4 Suppl 1):30-2. PubMed ID: 2315706
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of osteoarthritis with tiaprofenic acid: biochemical and histological protection against cartilage breakdown in the Pond-Nuki canine model.
    Howell DS, Pita JC, Muller FJ, Manicourt DH, Altman RD.
    J Rheumatol Suppl; 1991 Feb 10; 27():138-42. PubMed ID: 2027115
    [Abstract] [Full Text] [Related]

  • 16. Nonsteroidal antiinflammatory drugs in treatment of osteoarthritis.
    Brandt KD, Slowman-Kovacs S.
    Clin Orthop Relat Res; 1986 Dec 10; (213):84-91. PubMed ID: 3780106
    [Abstract] [Full Text] [Related]

  • 17. Biochemical aspects of osteoarthritis.
    Howell DS.
    Scand J Rheumatol Suppl; 1990 Dec 10; 81():5-7. PubMed ID: 2305220
    [Abstract] [Full Text] [Related]

  • 18. Effects of interleukin-1 and anti-inflammatory drugs on the degradation of human articular cartilage.
    Shinmei M, Kikuchi T, Masuda K, Shimomura Y.
    Drugs; 1988 Dec 10; 35 Suppl 1():33-41. PubMed ID: 2834169
    [Abstract] [Full Text] [Related]

  • 19. Effect of inhibition of matrix metalloproteinases on cartilage loss in vitro and in a guinea pig model of osteoarthritis.
    Sabatini M, Lesur C, Thomas M, Chomel A, Anract P, de Nanteuil G, Pastoureau P.
    Arthritis Rheum; 2005 Jan 10; 52(1):171-80. PubMed ID: 15641085
    [Abstract] [Full Text] [Related]

  • 20. Effects of nimesulide and naproxen on the degradation and metalloprotease synthesis of human osteoarthritic cartilage.
    Pelletier JP, Martel-Pelletier J.
    Drugs; 1993 Jan 10; 46 Suppl 1():34-9. PubMed ID: 7506192
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.